Jan Henrik ter Meulen, Chief Scientific Officer at Immune Design Corp. (IMDZ), sold 1,986 shares at $4.17 ($8K) on 2018-01-05, disclosed to the SEC on 2018-01-08.
Scheduled sale ($8k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |